Targeting sclerostin as potential treatment of osteoporosis.
about
Inactivation of Lrp5 in osteocytes reduces young's modulus and responsiveness to the mechanical loadingSclerostin Inhibition in the Management of OsteoporosisThe osteocyte as a therapeutic target in the treatment of osteoporosisModulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal OsteoporosisA review of osteocyte function and the emerging importance of sclerostinCrystallization and preliminary X-ray crystallographic analysis of the sclerostin-neutralizing Fab AbD09097.Association between sclerostin and bone density in chronic spinal cord injuryAbsence of sclerostin adversely affects B-cell survival.Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.New understanding and treatments for osteoporosis.Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation.Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?Appropriate models for novel osteoporosis drug discovery and future perspectives.Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.Genetic architecture of bone quality variation in layer chickens revealed by a genome-wide association study.Romosozumab: from basic to clinical aspects.Evaluation of serum myostatin and sclerostin levels in chronic spinal cord injured patients.Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.Expression of sclerostin scFv and the effect of sclerostin scFv on healing of osteoporotic femur fracture in rats.
P2860
Q24601727-F6581190-2FBB-4564-8623-355F2911433DQ26750713-D57F8E64-27CA-4FB2-959A-04E089CEC0BBQ27009129-EB6457FF-6342-470E-9486-77B5CF17776CQ27022580-579083EF-6211-4322-8ED5-659005E824B2Q34264395-81AEE0F2-F898-4280-86A6-A76AAAF4AD79Q35596559-7DA7C048-9A2C-475A-A061-6725E3E13FD2Q35782783-FBCF20FA-D6AF-4C4C-AC11-707A3F0A069DQ36040764-F010ADC6-240F-45DE-8DC9-69281CB3C3A0Q37206612-B2BEA820-C7F1-43E3-BB02-636536397F58Q37969683-5C3F1A54-F98A-4B80-9772-5D38807A0EC6Q38177814-C46FC51F-7BFD-4631-93E7-CA4BA936D775Q38230277-9C268957-1CBE-4837-8E00-D2C66CA621F7Q38570326-90FE9ABE-CF8C-49DD-8D10-D9F60BFADC13Q39180892-DAD3042B-CC07-4A93-B835-FCD8993A4F60Q40828040-843B3DF9-9C2C-4991-B9CD-C936F002A5E3Q42292645-5EDCB027-83CD-4592-9B51-F0EAC058297EQ45424127-6F745DCE-AAEC-4C88-836F-79ECF4A4795FQ50927799-339ABCA2-18F8-4414-BACA-A9EB528996E4Q51142825-77D59416-9081-478C-970F-03D942971F5FQ53088327-9A7D709A-FBB4-4056-B7DF-0E32B0D0D20C
P2860
Targeting sclerostin as potential treatment of osteoporosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting sclerostin as potential treatment of osteoporosis.
@en
Targeting sclerostin as potential treatment of osteoporosis.
@nl
type
label
Targeting sclerostin as potential treatment of osteoporosis.
@en
Targeting sclerostin as potential treatment of osteoporosis.
@nl
prefLabel
Targeting sclerostin as potential treatment of osteoporosis.
@en
Targeting sclerostin as potential treatment of osteoporosis.
@nl
P356
P1476
Targeting sclerostin as potential treatment of osteoporosis.
@en
P2093
Socrates E Papapoulos
P304
P356
10.1136/ARD.2010.141150
P407
P478
70 Suppl 1
P577
2011-03-01T00:00:00Z